Business News Distributed by GlobeNewswire
FDA has accepted a BLA for bentracimab, the first and only ticagrelor reversal agent, for filing and priority review
Pleasanton, CA and Philadelphia, PA, Aug. 02, 2024 (GLOBE NEWSWIRE) — SFJ Pharmaceuticals, (SFJ), Sponsor …